|
ORC2L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65076999999458E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.08809999963289E-07 |
| Normal-vs-Stage2 |
1.437920E-02 |
| Normal-vs-Stage3 |
4.538400E-02 |
| Normal-vs-Stage4 |
1.497220E-01 |
| Stage1-vs-Stage2 |
9.290600E-01 |
| Stage1-vs-Stage3 |
4.760000E-02 |
| Stage1-vs-Stage4 |
6.941300E-03 |
| Stage2-vs-Stage3 |
2.487600E-01 |
| Stage2-vs-Stage4 |
1.343180E-01 |
| Stage3-vs-Stage4 |
5.745000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.57370999999129E-05 |
| Normal-vs-AfricanAmerican |
3.708600E-01 |
| Normal-vs-Asian |
6.95360000024792E-07 |
| Caucasian-vs-AfricanAmerican |
9.888100E-02 |
| Caucasian-vs-Asian |
5.019800E-02 |
| AfricanAmerican-vs-Asian |
6.435100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.082600E-03 |
| Normal-vs-Female |
2.05300000333253E-08 |
| Male-vs-Female |
1.586900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.838800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.451399999992E-05 |
| Normal-vs-Age(61-80Yrs) |
1.629080E-04 |
| Normal-vs-Age(81-100Yrs) |
1.641800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.685900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.546200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.866390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.527400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.081000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.980600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.55400000004347E-06 |
| Normal-vs-Grade 2 |
1.55029999948653E-08 |
| Normal-vs-Grade 3 |
4.742700E-03 |
| Normal-vs-Grade 4 |
7.479400E-01 |
| Grade 1-vs-Grade 2 |
2.211800E-01 |
| Grade 1-vs-Grade 3 |
2.994000E-02 |
| Grade 1-vs-Grade 4 |
9.041800E-04 |
| Grade 2-vs-Grade 3 |
1.640420E-03 |
| Grade 2-vs-Grade 4 |
1.29390000003227E-06 |
| Grade 3-vs-Grade 4 |
1.393840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.12798659301916E-13 |
| Normal-vs-ccB subtype |
6.606200E-01 |
| ccA subtype-vs-ccB subtype |
4.37738734149207E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68710000000494E-05 |
| Normal-vs-N1 |
7.606400E-01 |
| N0-vs-N1 |
8.231700E-02 |
|
|
